HK1160106A1 - Process for the preparation of optically active (s)-(-)-2-(n-propylamino)- 5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds (s)-(-)-2-(n-)-5-(s)-(-)-2-(n- )-5- - Google Patents

Process for the preparation of optically active (s)-(-)-2-(n-propylamino)- 5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds (s)-(-)-2-(n-)-5-(s)-(-)-2-(n- )-5-

Info

Publication number
HK1160106A1
HK1160106A1 HK12100665.0A HK12100665A HK1160106A1 HK 1160106 A1 HK1160106 A1 HK 1160106A1 HK 12100665 A HK12100665 A HK 12100665A HK 1160106 A1 HK1160106 A1 HK 1160106A1
Authority
HK
Hong Kong
Prior art keywords
propylamino
methoxytetraline
preparation
optically active
hydroxytetraline
Prior art date
Application number
HK12100665.0A
Other languages
English (en)
Chinese (zh)
Inventor
.瑪奎拉斯奧倫德利茲
.博馬雷斯馬克
Original Assignee
因特奎姆私人控股公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41728366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1160106(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 因特奎姆私人控股公司 filed Critical 因特奎姆私人控股公司
Publication of HK1160106A1 publication Critical patent/HK1160106A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK12100665.0A 2008-10-13 2012-01-20 Process for the preparation of optically active (s)-(-)-2-(n-propylamino)- 5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds (s)-(-)-2-(n-)-5-(s)-(-)-2-(n- )-5- HK1160106A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200802890 2008-10-13
PCT/EP2009/063207 WO2010043571A1 (en) 2008-10-13 2009-10-09 Process for the preparation of optically active (s)-(-)-2-(n-propylamino)-5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds

Publications (1)

Publication Number Publication Date
HK1160106A1 true HK1160106A1 (en) 2012-08-10

Family

ID=41728366

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12100665.0A HK1160106A1 (en) 2008-10-13 2012-01-20 Process for the preparation of optically active (s)-(-)-2-(n-propylamino)- 5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds (s)-(-)-2-(n-)-5-(s)-(-)-2-(n- )-5-

Country Status (16)

Country Link
US (1) US8604242B2 (ko)
EP (1) EP2346811B1 (ko)
JP (1) JP5595404B2 (ko)
KR (1) KR101624760B1 (ko)
CN (1) CN102143937B (ko)
AU (1) AU2009305477B2 (ko)
BR (1) BRPI0920645A2 (ko)
CA (1) CA2735101C (ko)
CL (1) CL2011000830A1 (ko)
ES (1) ES2396066T3 (ko)
HK (1) HK1160106A1 (ko)
IL (1) IL211791A (ko)
MX (1) MX2011003930A (ko)
PE (1) PE20110366A1 (ko)
RU (1) RU2473538C2 (ko)
WO (1) WO2010043571A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473538C2 (ru) 2008-10-13 2013-01-27 Интерким, С.А. СПОСОБ ПОЛУЧЕНИЯ (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-МЕТОКСИТЕТРАЛИНА И (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-ГИДРОКСИТЕТРАЛИНА, ИХ СОЛИ С N-(3,5-ДИНИТРОБЕНЗОИЛ)-α-ФЕНИЛГЛИЦИНОМ, СПОСОБ ПОЛУЧЕНИЯ (6S)-(-)-5,6,7,8-ТЕТРАГИДРО-6-[ПРОПИЛ(2-ТИЕНИЛ)ЭТИЛ]АМИНО-1-НАФТОЛА (РОТИГОТИНА) (ВАРИАНТЫ)
JP5748848B2 (ja) 2010-06-25 2015-07-15 ウーツェーベー ファルマ ゲーエムベーハーUcb Pharma Gmbh 窒素置換(s)−5−アルコキシ−2−アミノテトラリン誘導体の分割方法
CN102070470A (zh) * 2010-11-05 2011-05-25 天津药物研究院 制备s(-)2-(n-正丙基)胺基-5-甲氧基四氢萘的方法
US8809590B2 (en) * 2011-06-27 2014-08-19 Shan Dong Luye Pharmaceutical Co., Ltd. Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol
EP2816030A1 (en) * 2013-06-20 2014-12-24 Duke Chem, S. A. Process for the preparation of frovatriptan and its enantiomer
CN113234057B (zh) * 2021-06-03 2022-12-02 成都工业学院 一种罗替戈汀的制备方法
CN114805095B (zh) * 2022-05-11 2023-07-21 上海柏狮生物科技有限公司 一种(s)-5-甲氧基-1,2,3,4-四氢-n-丙基-2-萘胺的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4657925A (en) 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US4564628A (en) 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
US4584828A (en) * 1984-05-07 1986-04-29 Bentley Robert J Brush rake
US4885308A (en) 1984-08-13 1989-12-05 Nelson Research & Development Co. Method and compositions for treatment of parkinsonism syndrome in mammals
US5234945A (en) 1989-05-09 1993-08-10 Whitby Research, Inc. Method of producing body weight and food intake using a dopamine D2 receptor agonist
EP0483152A4 (en) * 1989-05-09 1992-12-02 Whitby Research Incorporated A method of reducing body weight and food intake using a dopamine d2 receptor agonist
JP2785879B2 (ja) * 1989-05-31 1998-08-13 ジ・アップジョン・カンパニー 治療学的に有用な2―アミノテトラリン誘導体
US4968837A (en) 1989-07-28 1990-11-06 Ethyl Corporation Resolution of racemic mixtures
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
US5442117A (en) * 1993-12-13 1995-08-15 Albemarle Corporation Enantiomeric resolution
JP2002265460A (ja) * 2000-12-28 2002-09-18 Takeda Chem Ind Ltd 光学活性2,3−ジヒドロベンゾフラン化合物の製造法
WO2002053551A1 (fr) 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Procede de preparation de composes a base de 2,3-dihydrobenzofurane a activite optique
ES2200699B1 (es) * 2002-07-12 2005-10-01 Ragactives, S.L Procedimiento para la separacion de r(-) y s(+)-5-(2-((2-(etoxifenoxi)etil)amino)propil-2-metoxibenceno-sulfonamida.
DE10359528A1 (de) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S)-2-N-Propylamino-5-hydroxytetralin als D3-agonistisches Therapeutikum
DE10361258A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
RU2473538C2 (ru) 2008-10-13 2013-01-27 Интерким, С.А. СПОСОБ ПОЛУЧЕНИЯ (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-МЕТОКСИТЕТРАЛИНА И (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-ГИДРОКСИТЕТРАЛИНА, ИХ СОЛИ С N-(3,5-ДИНИТРОБЕНЗОИЛ)-α-ФЕНИЛГЛИЦИНОМ, СПОСОБ ПОЛУЧЕНИЯ (6S)-(-)-5,6,7,8-ТЕТРАГИДРО-6-[ПРОПИЛ(2-ТИЕНИЛ)ЭТИЛ]АМИНО-1-НАФТОЛА (РОТИГОТИНА) (ВАРИАНТЫ)

Also Published As

Publication number Publication date
JP2012505183A (ja) 2012-03-01
AU2009305477A1 (en) 2010-04-22
AU2009305477B2 (en) 2014-04-17
EP2346811B1 (en) 2012-08-15
CN102143937B (zh) 2014-07-02
EP2346811A1 (en) 2011-07-27
IL211791A0 (en) 2011-06-30
BRPI0920645A2 (pt) 2016-01-12
CA2735101A1 (en) 2010-04-22
US20110152543A1 (en) 2011-06-23
KR101624760B1 (ko) 2016-05-26
RU2473538C2 (ru) 2013-01-27
WO2010043571A1 (en) 2010-04-22
MX2011003930A (es) 2011-05-03
US8604242B2 (en) 2013-12-10
KR20110069036A (ko) 2011-06-22
ES2396066T3 (es) 2013-02-19
RU2011119224A (ru) 2012-11-20
CA2735101C (en) 2015-09-29
PE20110366A1 (es) 2011-06-20
CL2011000830A1 (es) 2012-03-30
CN102143937A (zh) 2011-08-03
IL211791A (en) 2014-06-30
JP5595404B2 (ja) 2014-09-24

Similar Documents

Publication Publication Date Title
IL196234A0 (en) A process for the preparation of optically active cyclopropylamines
IL211701A0 (en) Process for the preparation of bendamustine
IL196779A0 (en) Process for the preparation of optically active chiral amines
SG10201510576WA (en) Optically active diazabicyclooctane derivative and process for preparing the same
PL2133091T3 (pl) Kompozycje zawierające supramolekularne układy insuliny użyteczne do leczenia cukrzycy
HK1160106A1 (en) Process for the preparation of optically active (s)-(-)-2-(n-propylamino)- 5-methoxytetraline and (s)-(-)-2-(n-propylamino)-5-hydroxytetraline compounds (s)-(-)-2-(n-)-5-(s)-(-)-2-(n- )-5-
HUE038302T2 (hu) Eljárás védett L-alanin-származékok elõállítására
EP2372018A4 (en) AQUEOUS DISPERSION FOR THE TREATMENT OF FIBERS
ZA201101836B (en) Process for the preparation of rufinamide
PL2151428T3 (pl) Nowy sposób syntezy agomelatyny
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
ZA200907191B (en) Process for the preparation of gefitiib
EP2374799A4 (en) PROCESS FOR PREPARING 4- (1-HYDROXY-1-METHYLETHYL) -2-PROPYLIMIDAZOLE-5-CARBOXYLATE
IL208792A0 (en) Process for the preparation of amides
PL2344489T3 (pl) Sposób otrzymywania winpocetyny i apowinkaminy
FI20070395A (fi) Fotokatalyyttisesti aktiivinen koostumus ja menetelmä sen valmistamiseksi
IL196474A0 (en) Improved process for the preparation of voriconazole
PT2151429E (pt) Novo processo de síntese da agomelatina
IL243809A0 (en) Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds
DK2245000T3 (da) Fremgangsmåde til fremstilling af optisk aktive alfa-aminoacetaler
IL213520A0 (en) Process for the preparation of optically active compounds using transfer hydrogenation
EG26332A (en) Process for the preparation of benzonoprons
EP2203441A4 (en) PROCESS FOR OPTICALLY ACTIVE SULFOXIDE COMPOUNDS
ZA201007147B (en) Adhesive formulation and process for the treatment of reinforcing inserts
EP2243769A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE FLUORAMINE